Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Nektar Therapeutics
Business Segments
Geographic
Revenue
Revenue
Nektar Therapeutics
·
Geographic
·
1 segment
·
Rolls up to
Total Revenue
Breakdown
Segments
Geographic
View metric
Annual
Segment
FY'21
FY'22
FY'23
FY'24
FY'25
Geographic
$91.79M
$82.21M
$78.64M
$97.05M
$55.23M
Total
$101.91M
$92.06M
$90.12M
$98.43M
$55.23M
All segment values are derived from annual filings.